ReCon Chat with Bob...
Health Care: Drugs
Johnson & Johnson (JNJ: NYSE)
$87.21 -0.59 | -0.67%
05/23/13 - 04:00 PM ET
Portfolios with JNJ
- Portfolio NameUser Type
- ProGeorge Soros
- UserSlip's Portfolio
- Userralphd5-12
- ContributorStocks Fund Managers Love Q...
- ContributorGame of Thrones Portfolio
- UserCapt Jer
- ContributorRocket Stocks for the Week ...
- ContributorShort Squeezes for the Week...
- UserQuicksilver55
- Userlennyvb Portfolio 1
Latest JNJ Headlines from TheStreet
- An Investor's Choice: J&J or Baxter International? 04.19.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Haves and Have-Nots 04.17.13 | 08:04 pm
- 3 Stocks Advancing The Health Care Sector 04.17.13 | 01:04 pm
- Cramer's 6 Stocks in 60 Seconds: ESRX URI BBBY JNJ WDAY TGT 04.17.13 | 12:04 pm
- 5 Stocks Fund Managers Love for 2013 04.17.13 | 11:04 am
- Dow Today: Johnson & Johnson (JNJ) Leads The Day Higher, Bank Of America Corporation (BAC) Lags 04.17.13 | 10:04 am
- Google Offers Next Key Earnings Report 04.17.13 | 08:04 am
- Cramer's Top Stock Picks: KO JNJ GLD HK 04.17.13 | 06:04 am
- Dow Today: Johnson & Johnson (JNJ) Higher 04.16.13 | 11:04 am
- Morning Briefing: 10 Things You Should Know 04.16.13 | 08:04 am
Press Releases for JNJ
- Johnson & Johnson Pharmaceuticals Segment Poised To Continue Driving Growth With More Than 10 Potential New Product Filings By 2017 - PR Newswire 05.23.13 | 07:05 am
- Janssen And Johnson & Johnson To Provide Webcast Presentation Of Simeprevir Phase 3 Clinical Data Presented At The International Liver Congress Of The European Association For The Study Of The Liver (EASL) - PR Newswire 05.02.13 | 05:05 pm
- Johnson & Johnson Announces Dividend Increase Of 8.2% - PR Newswire 04.25.13 | 10:04 am
- Johnson & Johnson To Host Pharmaceuticals Business Review - PR Newswire 04.23.13 | 10:04 am
- Johnson & Johnson Announces Sale Of Elan American Depositary Shares To Elan - PR Newswire 04.18.13 | 09:04 am
- Johnson & Johnson To Webcast Annual Meeting Of Shareholders - PR Newswire 04.11.13 | 07:04 am
- Look And Feel Great This Spring, Despite Allergy Symptoms - PR Newswire 04.09.13 | 07:04 am
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Johnson & Johnson To Host Analyst Conference Call On First-Quarter Results - PR Newswire 03.19.13 | 10:03 am
- Cordis Acquires Flexible Stenting Solutions, Inc. - Business Wire 03.12.13 | 09:03 am
Partner Headlines for JNJ
- Alkermes Earnings Beat Estimates, But Outlook Unclear - Investor's Business Daily 05.23.13 | 06:05 pm
- Workday's Loss Narrows in 1Q - Analyst Blog - Zacks 05.23.13 | 03:05 pm
- Stock Market News for May 22, 2013 - Market News - Zacks 05.22.13 | 03:05 pm
- Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 23, 2013 - NASDAQ 05.22.13 | 01:05 pm
- Long-Term Biotech: 3 Names To Discover Now - Seeking Alpha 05.21.13 | 09:05 am
- Allergan, Inc. (AGN) Ex-Dividend Date Scheduled for May 21, 2013 - NASDAQ 05.20.13 | 01:05 pm
- Some Dividend ETFs Outperforming The S&P 500 - Investor's Business Daily 05.16.13 | 05:05 pm
- Nature's Sunshine Products, Inc. (NATR) Ex-Dividend Date Scheduled for May 16, 2013 - NASDAQ 05.15.13 | 01:05 pm
- Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for May 16, 2013 - NASDAQ 05.15.13 | 01:05 pm
- Dr. Marc Faber's Gloomy Market Outlook - Seeking Alpha 05.14.13 | 09:05 am
